ALLO
ALLO
US0197701065
Allogene Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
504.42M EUR
718.32M EUR
597.35M EUR
314.3M EUR
Enterprise Value
230.09M EUR
750.05M EUR
639.68M EUR
345.86M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-2.37x
--
--
--
Price to Sales
108.71x
154.81x
--
--
Price to Book
1.16x
1.65x
2.14x
1.07x
EV/Revenue
49.59x
161.65x
--
--
EV/EBITDA
-1.36x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-12.58%
-14.28%
-18.34%
-30.74%
ende